Melqart Asset Management (Uk) LTD Alnylam Pharmaceuticals, Inc. Transaction History
Melqart Asset Management (Uk) LTD
- $1.18 Billion
- Q2 2024
A detailed history of Melqart Asset Management (Uk) LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Melqart Asset Management (Uk) LTD holds 13,500 shares of ALNY stock, worth $3.73 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
13,500Holding current value
$3.73 Million% of portfolio
0.28%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
614Shares Held
108MCall Options Held
2.33MPut Options Held
2.17M-
Capital World Investors Los Angeles, CA15MShares$4.13 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.45 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.64 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.71 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.67 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...